Inhibitors of protein kinases
AssigneeAstraZeneca AB
InventorsLutz Zeitlmann, Andre Niestroj, Ulrich Heiser
Life of this patent
Estimating the term…
Abstract
Compounds of general Formula (I): wherein R1, R2, R3, Ra, A, B and x are as defined herein are inhibitors of protein kinases in particular members of the cyclin-dependent kinase family and/or the glycogen synthase kinase 3 family and are useful in preventing and/or treating any type of pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases and neurodegenerative diseases.
Claims13
A method for the treatment of pain, the method comprising administering to a subject in need of such treatment an effective amount of a compound of Formula (I):
- or a pharmaceutically acceptable salt, polymorph, tautomer and stereoisomer thereof wherein:
- Ra is H or methyl;
- R1 is selected from the group consisting of:
- carbocyclic or —C1-6 alkyl-carbocyclic, wherein the carbocyclic group is cyclohexyl or cyclopentyl;
- heterocyclic or —C1-6 alkyl-heterocyclic group, wherein the heterocyclic group is piperidine, piperazine, morpholine or pyrrolidine;
- aryl or alkyl-aryl;
- heteroaryl or —C1-6 alkyl-heteroaryl, wherein the heteroaryl group is pyridine, thiazole or thiophene;
- wherein any of the aforesaid carbocyclic, heterocyclic, aryl or heteroaryl groups may optionally be substituted by one or more groups independently selected from:
- halo, OH, NH2 and, for carbocyclic and heterocyclic groups, ═O;
- or
- C1-4 alkyl, —O(C1-4 alkyl), —NH(C1-4 alkyl), —NHC(O)(C1-4 alkyl), —S(C1-4 alkyl), —SO(C1-4 alkyl), —SO2(C1-4 alkyl) or —SO2NH(C1-4 alkyl) any of which may be further substituted with halo or OH;
- or
- R3, —C1-4 alkyl-R3, OR3, NHR3, —NHC1-4 alkyl-R3, —OC1-4 alkyl-R3, SR3, SOR3 or SO2R3;
- wherein R3 is an aryl, heteroaryl, carbocyclic or heterocyclic group any of which may be substituted with one or more halo, C1-4 alkyl, —O(C1-4 alkyl), NH2, —NH(C1-4 alkyl), —C(O)(C1-4 alkyl), —NHC(O)(C1-4 alkyl) groups, any of which alkyl groups may be substituted with halo or OH;
- each R2 is independently halo, OH, NH2;
- or
- C1-4 alkyl, —O(C1-4 alkyl), —NH(C1-4 alkyl), —C(O)(C1-4 alkyl), any of which may be further substituted with halo or OH;
- or
- R4, —C1-4 alkyl-R4, OR4, NHR4, alkyl-R4, —OC1-4 alkyl-R4, SR4, SOR4 or SO2R4;
- wherein R4 is an aryl, heteroaryl, carbocyclic or heterocyclic group any of which may be further substituted with one or more halo, OH, C14 alkyl, —O(C1-4 alkyl), NH2, —NH(C1-4 alkyl), —C(O)(C1-4 alkyl), —NHC(O)(C1-4 alkyl) groups, any of which alkyl groups may be substituted with halo or OH;
- and
- x is 0-4.
Dependencies are inferred from the claim text.